Disposable Endoscopes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Hospitals is the fastest growing sector, North America is the largest market

The global disposable endoscopes market is projected to expand significantly, from USD 3.51 billion in 2025 to USD 5.52 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 7.84%. These sterile, single-use medical devices are designed for immediate disposal after one procedure, thereby eliminating the intricate reprocessing steps necessary for conventional reusable instruments. This market's growth is primarily fueled by the critical necessity to reduce hospital-acquired infections, especially those caused by multidrug-resistant organisms transmitted via contaminated duodenoscopes and bronchoscopes. Furthermore, healthcare facilities are increasingly adopting these devices to improve operational efficiency, bypassing the labor expenses, downtime, and risks of chemical exposure associated with cleaning and sterilization.

However, a notable challenge to the widespread adoption of disposable endoscopes is the considerable environmental impact of single-use plastics. The substantial volume of medical waste generated by these devices raises significant sustainability concerns that institutions are actively working to address. For instance, in 2025, the reprocessing of single-use devices by healthcare facilities diverted over 12 million pounds of waste from landfills, as reported by the Association of Medical Device Reprocessors, underscoring the substantial ecological footprint that would otherwise result from the disposable endoscopy sector.

Market Drivers

The primary force driving the global disposable endoscopes market is the urgent need to prevent cross-contamination and hospital-acquired infections (HAIs). Reusable devices, especially duodenoscopes with their intricate elevator mechanisms, pose considerable sterilization challenges and have frequently been implicated in transmitting multidrug-resistant organisms. This critical safety concern has prompted a swift shift towards sterile, single-use alternatives that inherently eliminate the pathway for pathogen transmission between patients. For instance, Ambu A/S reported in their 'Annual Report 2024/25' (November 2025) a 15.4% organic growth in their Endoscopy Solutions business, directly attributing this surge to the accelerated adoption of single-use modalities in response to pressing infection control mandates.

Concurrently, swift technological progress in single-use endoscopic imaging is overcoming past adoption hurdles by providing visualization quality comparable to traditional reusable platforms. Advances in high-definition digital sensors and ergonomic designs have made these disposable devices clinically viable for more complex procedures, consequently increasing their acceptance among physicians in various healthcare settings.

This enhanced clinical utility is fueling significant commercial growth as providers seek to balance performance with operational efficiency. Boston Scientific, in their 'Q4 2024 Financial & Operational Highlights' (February 2025), noted double-digit growth in their single-use imaging franchises, reflecting the increasing use of these advanced technologies. The endoscopy sector operates on a substantial scale; Boston Scientific's Endoscopy segment alone generated net sales of $2.68 billion in 2025, highlighting the strong market supporting these disposable innovations.

Market Challenges

A significant impediment to the wider growth of the global disposable endoscopes market is the substantial environmental impact linked to single-use medical devices. With healthcare systems worldwide pursuing ambitious carbon neutrality objectives, the buildup of non-biodegradable plastic waste directly conflicts with institutional sustainability requirements. This environmental burden compels hospital administrators to carefully balance the infection-control advantages of disposable scopes against the potential reputational damages and operational difficulties of handling increased medical waste, frequently leading procurement departments to delay transitioning from reusable equipment.

The considerable scale of this carbon footprint acts as a tangible barrier to adoption. The manufacturing and disposal of these devices contribute significantly to greenhouse gas emissions, an aspect under increasing scrutiny from regulatory authorities. For instance, the Association of Medical Device Reprocessors reported that in 2024, the sector needed to eliminate over 23 million pounds of CO2 emissions through reprocessing efforts to lessen this impact. This statistic highlights the immense potential carbon load inherent in the single-use supply chain, which continues to hinder the market's growth prospects during a period of heightened environmental responsibility.

Market Trends

A significant market trend involves the emergence of sustainable and biodegradable device materials, serving as a crucial response to the environmental issues stemming from high volumes of medical waste. Manufacturers are increasingly advancing beyond basic recycling efforts to fundamentally rethink device construction, incorporating bio-based polymers to lessen reliance on fossil fuels in production. This evolution enables healthcare facilities to retain the sterility and workflow advantages of single-use instruments while actively lowering their carbon footprint, a consideration that is increasingly pivotal in hospital purchasing decisions. As reported by Ambu A/S in their 'Annual Report 2024/25' (November 2025), the company has successfully integrated bioplastics into the handles of all its current endoscopes, setting a new industry standard for reducing the ecological impact of disposable medical devices.

Concurrently, the market is experiencing a notable diversification into specialized urology and bronchoscopy applications, extending beyond the conventional gastrointestinal segment. This trend is fueled by the inherent complexity and vulnerability of reusable ureteroscopes and bronchoscopes, which are susceptible to damage during reprocessing and pose ongoing risks of cross-contamination. Consequently, healthcare providers are quickly adopting high-performance disposable alternatives for these intricate procedures to ensure both consistent device availability and patient safety. This strong adoption is reflected in financial results; Boston Scientific's 'Q4 2024 Financial & Operational Highlights' (February 2025) indicated double-digit organic revenue growth in their single-use imaging franchises, highlighting the accelerating demand for specialized disposable platforms in urological and biliary interventions.

Key Market Players

• Olympus Corporation
• Karl Storz SE
• Ambu A/S
• Boston Scientific Corporation
• obp Surgical Corporation
• CooperSurgical Inc.
• HOYA Corporation
• Shenzhen HugeMed Medical Technical Development Co., Ltd.

Report Scope

In this report, the Global Disposable Endoscopes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Disposable Endoscopes Market, by Type:

• Laparoscopes
• Arthroscopes
• Ureteroscopes
• Cystoscopes
• Gynecology Endoscopes
• Neuroendoscopes
• Bronchoscopes
• Hysteroscopes
• Laryngoscopes
• Otoscopes
• Sigmoidoscopes
• Duodenoscopes
• Nasopharyngoscopes
• Rhinoscopes
• Colonoscopes

Disposable Endoscopes Market, by End User:

• Hospitals
• Outpatient Facilities

Disposable Endoscopes Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Disposable Endoscopes Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.